Timothy C. Dec - 22 Feb 2024 Form 4 Insider Report for SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Role
Senior Vice-President & CFO
Signature
/s/ Timothy C. Dec
Issuer symbol
SUPN
Transactions as of
22 Feb 2024
Net transactions value
$0
Form type
4
Filing time
26 Feb 2024, 17:00:44 UTC
Previous filing
13 Oct 2023
Next filing
27 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SUPN Common Stock Award $0 +500 +9.1% $0.000000 6,004 22 Feb 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SUPN Restricted Stock Unit Disposed to Issuer $0 -500 -33% $0.000000 1,000 22 Feb 2024 Common Stock 500 Direct F2, F3
transaction SUPN Restricted Stock Unit Award $0 +12,000 $0.000000 12,000 22 Feb 2024 Common Stock 12,000 Direct F2, F4
transaction SUPN Employee Stock Option (Right to Buy) Award $0 +50,000 $0.000000 50,000 22 Feb 2024 Common Stock 50,000 $27.94 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes an aggregate of 415 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan.
F2 Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting.
F3 These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2023.
F4 These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2025.
F5 The option vests in four equal annual installments beginning on February 22, 2025.